Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Change in Account Payables (2023 - 2025)

Zenas BioPharma has reported Change in Account Payables over the past 3 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Change in Account Payables at $1.1 million for Q4 2025, down 79.41% from a year ago — trailing twelve months through Dec 2025 was -$10.0 million (down 185.55% YoY), and the annual figure for FY2025 was -$10.0 million, down 185.55%.
  • Change in Account Payables for Q4 2025 was $1.1 million at Zenas BioPharma, up from -$2.0 million in the prior quarter.
  • Over the last five years, Change in Account Payables for ZBIO hit a ceiling of $5.4 million in Q4 2024 and a floor of -$12.1 million in Q2 2025.
  • Median Change in Account Payables over the past 3 years was $2.9 million (2025), compared with a mean of $535222.2.
  • Biggest five-year swings in Change in Account Payables: soared 73.75% in 2024 and later crashed 2418.12% in 2025.
  • Zenas BioPharma's Change in Account Payables stood at $3.1 million in 2023, then soared by 73.75% to $5.4 million in 2024, then plummeted by 79.41% to $1.1 million in 2025.
  • The last three reported values for Change in Account Payables were $1.1 million (Q4 2025), -$2.0 million (Q3 2025), and -$12.1 million (Q2 2025) per Business Quant data.